SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001387131-19-007448
Filing Date
2019-10-04
Accepted
2019-10-04 16:16:28
Documents
1
Group Members
BONDERMAN FAMILY LIMITED PARTNERSHIPINFINITY Q CAPITAL MANAGEMENT, LLCINFINITY Q DIVERSIFIED ALPHA FUNDINFINITY Q MANAGEMENT EQUITY, LLCJAMES VELISSARISLEONARD A. POTTERWILDCAT - LIQUID ALPHA, LLC

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP urgn-sc13g_092619.htm SC 13G 199331
  Complete submission text file 0001387131-19-007448.txt   201068
Mailing Address 888 SEVENTH AVENUE NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE NEW YORK NY 10106 212-468-5100
Wildcat Capital Management, LLC (Filed by) CIK: 0001582384 (see all company filings)

IRS No.: 453715536 | State of Incorp.: DE | Fiscal Year End: 1213
Type: SC 13G

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89992 | Film No.: 191138799
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences